BI-1819479
- Generic Name
- BI-1819479
A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)
Phase 2
Active, not recruiting
- Conditions
- Idiopathic Pulmonary Fibrosis
- Interventions
- Drug: Placebo matching BI 1819479
- First Posted Date
- 2024-03-28
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 300
- Registration Number
- NCT06335303
- Locations
- 🇦🇷
CEDIC - Centro de Investigacion Clinica, Caba, Argentina
🇦🇷Centro de Investigación Clinica Belgrano, Caba, Argentina
🇺🇸University of Alabama at Birmingham, Birmingham, Alabama, United States
A Study in Healthy Men to Test How Well Different Doses of BI 1819479 Are Tolerated
- First Posted Date
- 2022-07-22
- Last Posted Date
- 2023-04-05
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 24
- Registration Number
- NCT05469646
- Locations
- 🇯🇵
SOUSEIKAI Sumida Hospital, Tokyo, Sumida-ku, Japan
A Study in Healthy Men to Test How Esomeprazole Influences the Amount of BI 1819479 in the Blood
- First Posted Date
- 2022-07-20
- Last Posted Date
- 2023-01-26
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 15
- Registration Number
- NCT05467475
- Locations
- 🇩🇪
Humanpharmakologisches Zentrum Biberach, Biberach, Germany
A Study to Test How Healthy Women Tolerate Different Doses of BI 1819479
- First Posted Date
- 2022-07-01
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 62
- Registration Number
- NCT05440799
- Locations
- 🇩🇪
CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany
A Study in Healthy Men to Test How Well Different Doses of BI 1819479 Are Tolerated and Taken up by the Body With or Without Food
- First Posted Date
- 2021-03-17
- Last Posted Date
- 2022-05-04
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 66
- Registration Number
- NCT04801693
- Locations
- 🇩🇪
CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath